Danaher Corporation $DHR Shares Bought by Courier Capital LLC

Courier Capital LLC grew its holdings in shares of Danaher Corporation (NYSE:DHR) by 1,083.9% in the 3rd quarter, Holdings Channel.com reports. The firm owned 39,176 shares of the conglomerate’s stock after purchasing an additional 35,867 shares during the quarter. Danaher makes up approximately 1.6% of Courier Capital LLC’s investment portfolio, making the stock its 14th largest position. Courier Capital LLC’s holdings in Danaher were worth $8,679,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also modified their holdings of the business. Financial Planning Hawaii Inc. bought a new position in shares of Danaher in the third quarter worth about $764,000. Downshift Financial LLC grew its stake in shares of Danaher by 2,133.3% during the 3rd quarter. Downshift Financial LLC now owns 201 shares of the conglomerate’s stock valued at $45,000 after acquiring an additional 192 shares during the period. First County Bank CT grew its stake in shares of Danaher by 581.1% during the 3rd quarter. First County Bank CT now owns 10,604 shares of the conglomerate’s stock valued at $2,349,000 after acquiring an additional 9,047 shares during the period. McGlone Suttner Wealth Management Inc. increased its holdings in Danaher by 528.6% in the 3rd quarter. McGlone Suttner Wealth Management Inc. now owns 11,818 shares of the conglomerate’s stock worth $2,618,000 after acquiring an additional 9,938 shares in the last quarter. Finally, Sivik Global Healthcare LLC increased its holdings in Danaher by 25.0% in the 3rd quarter. Sivik Global Healthcare LLC now owns 25,000 shares of the conglomerate’s stock worth $5,539,000 after acquiring an additional 5,000 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR stock traded up $2.10 during trading hours on Tuesday, hitting $223.30. The stock had a trading volume of 6,007,508 shares, compared to its average volume of 4,462,041. The stock’s 50-day moving average price is $211.85 and its two-hundred day moving average price is $194.88. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock has a market capitalization of $156.98 billion, a price-to-earnings ratio of 39.66, a PEG ratio of 2.74 and a beta of 0.76. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The firm’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter last year, the business posted $0.77 EPS. Equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is presently 28.42%.

Analyst Ratings Changes

A number of equities research analysts have commented on the stock. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 target price on shares of Danaher in a research note on Wednesday, July 22nd. Royal Bank Of Canada upped their price target on shares of Danaher from $215.00 to $250.00 and gave the stock an “outperform” rating in a research report on Monday, October 5th. Barclays increased their price objective on shares of Danaher from $230.00 to $255.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 7th. TD Cowen raised their price objective on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday. Two equities research analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating and four have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $235.41.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.